Atay Oguzhan, an officer and director at BillionToOne, Inc., has reported the sale of 25,001 shares of the company's Class A stock. The transaction, filed on November 2, 2026, is valued at approximately $2.83 million. This sale is significant as it reflects ongoing executive activity within the company and may influence investor perceptions.

BillionToOne, Inc. operates in the medical laboratories sector, as indicated by its Standard Industrial Classification. The company is incorporated in Delaware and is headquartered in Menlo Park, California. The recent filing is part of a series of transactions that Oguzhan has engaged in, highlighting his active role in the company.

The filing states, "Atay Oguzhan sold 25,001 shares of Class A stock on November 2, 2026, as part of a stock option exercise." This indicates that the shares were acquired through a stock option plan, a common practice among executives to align their interests with those of shareholders.

This sale may impact various stakeholders, including other executives, shareholders, and potential investors. The ongoing activity in Oguzhan's account suggests a strategic approach to managing his holdings and could signal confidence or changes in the company’s direction.

Details were not available in the SEC filing regarding any future plans or additional transactions following this sale.